SG10201700435XA - Methods for prevention and treatment of preeclampsia - Google Patents

Methods for prevention and treatment of preeclampsia

Info

Publication number
SG10201700435XA
SG10201700435XA SG10201700435XA SG10201700435XA SG10201700435XA SG 10201700435X A SG10201700435X A SG 10201700435XA SG 10201700435X A SG10201700435X A SG 10201700435XA SG 10201700435X A SG10201700435X A SG 10201700435XA SG 10201700435X A SG10201700435X A SG 10201700435XA
Authority
SG
Singapore
Prior art keywords
preeclampsia
prevention
treatment
methods
Prior art date
Application number
SG10201700435XA
Inventor
Ayelet Chajut
Eytan Abraham
Original Assignee
Pluristem Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pluristem Ltd filed Critical Pluristem Ltd
Publication of SG10201700435XA publication Critical patent/SG10201700435XA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/35—Fat tissue; Adipocytes; Stromal cells; Connective tissues
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0605—Cells from extra-embryonic tissues, e.g. placenta, amnion, yolk sac, Wharton's jelly
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0653—Adipocytes; Adipose tissue
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2513/00—3D culture

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Rheumatology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
SG10201700435XA 2012-09-04 2013-08-31 Methods for prevention and treatment of preeclampsia SG10201700435XA (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261696442P 2012-09-04 2012-09-04
US201361815760P 2013-04-25 2013-04-25
US201361825037P 2013-05-19 2013-05-19

Publications (1)

Publication Number Publication Date
SG10201700435XA true SG10201700435XA (en) 2017-02-27

Family

ID=49354724

Family Applications (2)

Application Number Title Priority Date Filing Date
SG10201700435XA SG10201700435XA (en) 2012-09-04 2013-08-31 Methods for prevention and treatment of preeclampsia
SG11201501065QA SG11201501065QA (en) 2012-09-04 2013-08-31 Methods for prevention and treatment of preeclampsia

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG11201501065QA SG11201501065QA (en) 2012-09-04 2013-08-31 Methods for prevention and treatment of preeclampsia

Country Status (11)

Country Link
US (1) US9950014B2 (en)
EP (1) EP2892542B1 (en)
JP (1) JP6371286B2 (en)
KR (1) KR101921787B1 (en)
CN (1) CN104768559B (en)
AU (1) AU2013311289B2 (en)
CA (1) CA2882687A1 (en)
HK (2) HK1211242A1 (en)
IL (1) IL237528B (en)
SG (2) SG10201700435XA (en)
WO (1) WO2014037863A1 (en)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3103463B1 (en) 2007-09-19 2020-01-01 Pluristem Ltd. Adherent cells from adipose or placenta tissues and use thereof in therapy
AU2009252722A1 (en) 2008-05-27 2009-12-03 Pluristem Ltd. Methods of treating inflammatory colon diseases
AU2009288781B2 (en) 2008-09-02 2015-01-29 Pluri Biotech Ltd Adherent cells from placenta tissue and use thereof in therapy
US9175262B2 (en) 2009-11-30 2015-11-03 Pluristerm Ltd. Adherent cells from placenta and use of same in disease treatment
ES2572211T3 (en) 2010-05-27 2016-05-30 Pluristem Ltd Skeletal muscle regeneration using mesenchymal stem cells
WO2012048275A2 (en) 2010-10-08 2012-04-12 Caridianbct, Inc. Configurable methods and systems of growing and harvesting cells in a hollow fiber bioreactor system
EP3260533B1 (en) 2011-03-22 2019-09-11 Pluristem Ltd. Methods for treating radiation or chemical injury
IL254464B2 (en) 2011-04-15 2023-12-01 Pluri Biotech Ltd Methods and systems for harvesting cells
US20150110751A1 (en) * 2012-05-16 2015-04-23 Kennedy Krieger Institute, Inc. Stem cells as an individualized maternal therapy for prevention of prematurity
SG11201500816XA (en) 2012-09-06 2015-03-30 Pluristem Ltd Devices and methods for culture of cells
CN105793411B (en) 2013-11-16 2018-04-17 泰尔茂比司特公司 Cell amplification in bioreactor
EP3114206B1 (en) 2014-03-04 2020-07-29 Pluristem Ltd. Systems and methods for growing and harvesting cells
EP3613841B1 (en) 2014-03-25 2022-04-20 Terumo BCT, Inc. Passive replacement of media
US20160090569A1 (en) 2014-09-26 2016-03-31 Terumo Bct, Inc. Scheduled Feed
WO2017004592A1 (en) 2015-07-02 2017-01-05 Terumo Bct, Inc. Cell growth with mechanical stimuli
EP3464565A4 (en) 2016-05-25 2020-01-01 Terumo BCT, Inc. Cell expansion
US11685883B2 (en) 2016-06-07 2023-06-27 Terumo Bct, Inc. Methods and systems for coating a cell growth surface
US11104874B2 (en) 2016-06-07 2021-08-31 Terumo Bct, Inc. Coating a bioreactor
JP7268943B2 (en) * 2016-07-11 2023-05-08 ボーナス セラピューティックス リミテッド Cell composition for tissue regeneration
CN110402147A (en) * 2016-12-05 2019-11-01 细胞结构公司 Lymphedema and associated disease are treated using placenta-derived adherent cells
US11624046B2 (en) 2017-03-31 2023-04-11 Terumo Bct, Inc. Cell expansion
JP7393945B2 (en) 2017-03-31 2023-12-07 テルモ ビーシーティー、インコーポレーテッド cell proliferation
KR102435297B1 (en) * 2020-07-21 2022-08-22 부산대학교 산학협력단 Biomarker composition for early diagnosing preeclampsia and method of diagnosis using the same
CN114195875B (en) * 2021-06-17 2022-07-12 南京市妇幼保健院 Placenta-derived endogenous polypeptide and application thereof

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5902741A (en) 1986-04-18 1999-05-11 Advanced Tissue Sciences, Inc. Three-dimensional cartilage cultures
US5629186A (en) 1994-04-28 1997-05-13 Lockheed Martin Corporation Porous matrix and method of its production
US6132463A (en) 1995-05-19 2000-10-17 Etex Corporation Cell seeding of ceramic compositions
ATE227338T1 (en) 1998-03-18 2002-11-15 Massachusetts Inst Technology VASCULARIZED PERFUSED ARRANGEMENTS FOR MICRO TISSUES AND MICRO ORGANS
US6153432A (en) 1999-01-29 2000-11-28 Zen-Bio, Inc Methods for the differentiation of human preadipocytes into adipocytes
DE60043534D1 (en) 1999-02-04 2010-01-28 Pluristem Ltd METHOD AND DEVICE FOR STABILIZING AND EXPANSIONING HEMATOPOIETIC STEM CELLS AND / OR PRE-CELL CELLS
AU2001238695B2 (en) 2000-02-26 2005-11-24 Artecel Sciences, Inc. Pleuripotent stem cells generated from adipose tissue-derived stromal cells and uses thereof
ATE544460T1 (en) * 2003-10-24 2012-02-15 Nora Therapeutics Inc COMPOSITIONS AND METHODS FOR A HEALTHY PREGNANCY
RU2271817C1 (en) * 2004-08-18 2006-03-20 ЗАО "РеМеТэкс" Biotransplant and method for treatment of lung hypertension
CN101163970A (en) * 2004-12-21 2008-04-16 耶鲁大学 Diagnosis of preeclampsia
US20110293583A1 (en) 2006-03-23 2011-12-01 Pluristem Ltd. Methods for cell expansion and uses of cells and conditioned media produced thereby for therapy
CN101558151B (en) * 2006-03-23 2015-10-21 普拉里斯坦有限公司 The purposes that methods for cell expansion and the cell produced by this and conditioned medium are used for the treatment of
MX2008012085A (en) 2006-03-23 2009-01-22 Pluristem Ltd Methods for cell expansion and uses of cells and conditioned media produced thereby for therapy.
US20110171182A1 (en) 2006-03-23 2011-07-14 Pluristem Ltd. Methods for cell expansion and uses of cells and conditioned media produced thereby for therapy
EP3103463B1 (en) 2007-09-19 2020-01-01 Pluristem Ltd. Adherent cells from adipose or placenta tissues and use thereof in therapy
AU2009252722A1 (en) 2008-05-27 2009-12-03 Pluristem Ltd. Methods of treating inflammatory colon diseases
WO2010017378A2 (en) * 2008-08-08 2010-02-11 Indiana University Research And Technology Corporation Methods and compositions for vasculogenic potential determination
AU2009288781B2 (en) 2008-09-02 2015-01-29 Pluri Biotech Ltd Adherent cells from placenta tissue and use thereof in therapy
EP2331957B1 (en) 2008-09-02 2016-11-02 Pluristem Ltd. Methods of selection of cells for transplantation
US9096827B2 (en) 2008-09-02 2015-08-04 Pluristem Ltd. Adherent cells from placenta tissue and use thereof in therapy
CN110187119B (en) * 2008-10-31 2022-07-29 耶鲁大学 Methods and compositions for the detection and treatment of preeclampsia
JP5869342B2 (en) * 2008-11-19 2016-02-24 アンスロジェネシス コーポレーション Amnion-derived adherent cells
WO2011044251A1 (en) * 2009-10-06 2011-04-14 The Cohen Mcniece Foundation Preparation and use of stromal cells for treatment of cardiac diseases
US9175262B2 (en) 2009-11-30 2015-11-03 Pluristerm Ltd. Adherent cells from placenta and use of same in disease treatment
EP2561066B1 (en) 2010-04-23 2016-03-30 Pluristem Ltd. Adherent stromal cells derived from plancentas of multiple donors and uses thereof
ES2572211T3 (en) 2010-05-27 2016-05-30 Pluristem Ltd Skeletal muscle regeneration using mesenchymal stem cells
CA2821809C (en) * 2010-12-17 2022-01-25 Anthrogenesis Corporation Treatment of immune-related diseases and disorders using amnion derived adherent cells
US20140017209A1 (en) 2011-03-22 2014-01-16 Pluristem Ltd. Methods for treating radiation or chemical injury
IL254464B2 (en) 2011-04-15 2023-12-01 Pluri Biotech Ltd Methods and systems for harvesting cells
ITTO20111183A1 (en) * 2011-12-21 2013-06-22 Univ Degli Studi Torino CONDITIONAL MEANS OBTAINED FROM PLACENTARY STEM CELLS AND ITS USE IN THE THERAPEUTIC TREATMENT OF PREECLAMPSIA
SG11201500816XA (en) 2012-09-06 2015-03-30 Pluristem Ltd Devices and methods for culture of cells
CA2883826A1 (en) 2012-10-31 2014-05-08 Pluristem Ltd. Method and device for thawing biological material
US10351910B2 (en) 2013-02-20 2019-07-16 Pluristem Ltd Gene and protein expression properties of adherent stromal cells cultured in 3D

Also Published As

Publication number Publication date
US9950014B2 (en) 2018-04-24
IL237528A0 (en) 2015-04-30
AU2013311289A1 (en) 2015-03-05
KR101921787B1 (en) 2018-11-23
JP2015532656A (en) 2015-11-12
SG11201501065QA (en) 2015-03-30
CA2882687A1 (en) 2014-03-13
US20150216907A1 (en) 2015-08-06
CN104768559B (en) 2019-01-22
HK1211242A1 (en) 2016-05-20
AU2013311289B2 (en) 2017-11-16
IL237528B (en) 2019-11-28
EP2892542B1 (en) 2018-04-04
CN104768559A (en) 2015-07-08
WO2014037863A1 (en) 2014-03-13
EP2892542A1 (en) 2015-07-15
HK1212239A1 (en) 2016-06-10
JP6371286B2 (en) 2018-08-08
KR20150047503A (en) 2015-05-04

Similar Documents

Publication Publication Date Title
HK1212239A1 (en) Methods for prevention and treatment of preeclampsia
HK1210502A1 (en) Methods and compositions for treatment of a genetic condition
EP2874647A4 (en) Method of diagnosis and treatment
DK3292875T3 (en) Compositions and methods for treating diseases
GB201217296D0 (en) Method of treatment and/or prevention
HUE063599T2 (en) Methods of treatment or reduction of edematous-fibrosclerotic panniculopathy
EP2908746A4 (en) Tools and methods for treatment of pelvic conditions
HK1210077A1 (en) Methods of treating or preventing respiratory conditions
EP2928456A4 (en) Methods and compositions for treatment of cancer
ZA201408058B (en) Compositions and methods for the treatment of epilepsy
EP2928460A4 (en) Methods for preventing and treating inflammatory skin conditions
EP2920289A4 (en) Methods for prevention and reduction of scale formation
ZA201501068B (en) Methods for prevention and treatment of preeclampsia
EP2825184A4 (en) Compositions and methods for treatment of pain
GB201309001D0 (en) Methods for prevention and treatment of preeclampsia
IL237490A0 (en) System and method for treatment of water
GB201221032D0 (en) Method of treatment
GB201207894D0 (en) Method of treatment
GB201221118D0 (en) Methods of treatment
GB201216748D0 (en) Methods of treatment
GB201216740D0 (en) Methods of treatment
GB201206326D0 (en) Methods of treatment
GB201206330D0 (en) Methods of treatment
GB201206325D0 (en) Methods of treatment
GB201206324D0 (en) Methods of treatment